Maura Tamony

Maura Tamony has extensive work experience in financial reporting and accounting roles. Maura started their career in 1989 at Banc One Corporation, where they held the position of AVP & Manager, Financial Planning & Analysis for nearly nine years. Maura then moved on to Bay View Capital Corporation as VP & Assistant Manager, Financial Reporting & Investor Relations. Following that, they worked as Corporate Finance Manager at Open TV. In 2004, they joined United Commercial Bank as VP & Assistant Controller and later transitioned to Bay View Capital Corp as VP & Manager of Financial Reporting. In 2006, they joined Genomic Health, Inc. as Associate Director, SEC Reporting, and held the role for nearly six years. From 2012 to 2016, they worked at Medivation in various roles, including Sr. Manager, SEC Reporting & Technical Accounting, and Associate Director, SEC Reporting & Technical Accounting. In 2016, they joined Medivation (Acquired by Pfizer, Inc.) as Director, External Reporting & Technical Accounting. Finally, in 2017, they joined Protagonist Therapeutics, where they have held roles such as Director, Financial Reporting, Sr. Director, Financial Reporting, and currently, Vice President, Financial Reporting.

Maura Tamony holds a Bachelor of Science degree in Accounting & Finance from the Lam Family College of Business at San Francisco State University. Maura obtained their degree but the specific start and end years are not provided. In addition to their degree, Maura has achieved certifications as a Certified Equity Professional (CEP) from the Certified Equity Professional Institute in January 2018. Maura is also a Certified Public Accountant in the State of Arizona, although the exact date of obtaining this certification is not mentioned.